These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15949941)

  • 1. Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes.
    Albasanz JL; Dalfó E; Ferrer I; Martín M
    Neurobiol Dis; 2005 Dec; 20(3):685-93. PubMed ID: 15949941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabotropic glutamate receptor/phospholipase C pathway: a vulnerable target to Creutzfeldt-Jakob disease in the cerebral cortex.
    Rodríguez A; Freixes M; Dalfó E; Martín M; Puig B; Ferrer I
    Neuroscience; 2005; 131(4):825-32. PubMed ID: 15749337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal metabotropic glutamate receptor expression and signaling in the cerebral cortex in diffuse Lewy body disease is associated with irregular alpha-synuclein/phospholipase C (PLCbeta1) interactions.
    Dalfó E; Albasanz JL; Martin M; Ferrer I
    Brain Pathol; 2004 Oct; 14(4):388-98. PubMed ID: 15605986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabotropic glutamate receptor/phospholipase C system in female rat heart.
    Iglesias I; Castillo CA; León D; Ruíz MA; Albasanz JL; Martín M
    Brain Res; 2007 Jun; 1153():1-11. PubMed ID: 17493590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease in GTP-sensitive high affinity agonist binding of muscarinic acetylcholine receptors in autopsied brains of dementia with Lewy bodies and Alzheimer's disease.
    Shiozaki K; Iseki E
    J Neurol Sci; 2004 Aug; 223(2):145-8. PubMed ID: 15337615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal group I metabotropic glutamate receptor expression and signaling in the frontal cortex in Pick disease.
    Dalfó E; Albasanz JL; Rodríguez A; Martín M; Ferrer I
    J Neuropathol Exp Neurol; 2005 Jul; 64(7):638-47. PubMed ID: 16042316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group I mGluR signaling in BSE-infected bovine-PrP transgenic mice.
    Rodríguez A; Martín M; Albasanz JL; Barrachina M; Espinosa JC; Torres JM; Ferrer I
    Neurosci Lett; 2006 Dec; 410(2):115-20. PubMed ID: 17084974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabotropic glutamate receptor/phospholipase C pathway is increased in rat brain at the end of pregnancy.
    León D; Castillo CA; Ruiz MA; Albasanz JL; Martín M
    Neurochem Int; 2007 Apr; 50(5):681-8. PubMed ID: 17303286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Beyer MK; Larsen JP; Aarsland D
    Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease.
    Ferrer I; Perez E; Dalfó E; Barrachina M
    Neurosci Lett; 2007 Mar; 415(3):205-9. PubMed ID: 17284347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of cholinergic neurons in the nucleus of the medial septum and the vertical limb of the diagonal band in dementia with Lewy bodies.
    Fujishiro H; Umegaki H; Isojima D; Akatsu H; Iguchi A; Kosaka K
    Acta Neuropathol; 2006 Feb; 111(2):109-14. PubMed ID: 16421740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer's disease.
    Lee HG; Ogawa O; Zhu X; O'Neill MJ; Petersen RB; Castellani RJ; Ghanbari H; Perry G; Smith MA
    Acta Neuropathol; 2004 Apr; 107(4):365-71. PubMed ID: 14872255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofilament-immunoreactive neurons in Alzheimer's disease and dementia with Lewy bodies.
    Shepherd CE; McCann H; Thiel E; Halliday GM
    Neurobiol Dis; 2002 Mar; 9(2):249-57. PubMed ID: 11895376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: diagnosis and gender effects.
    Ballmaier M; O'Brien JT; Burton EJ; Thompson PM; Rex DE; Narr KL; McKeith IG; DeLuca H; Toga AW
    Neuroimage; 2004 Sep; 23(1):325-35. PubMed ID: 15325380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between Alzheimer's disease and dementia with Lewy bodies: an fMRI study of task-related brain activity.
    Sauer J; ffytche DH; Ballard C; Brown RG; Howard R
    Brain; 2006 Jul; 129(Pt 7):1780-8. PubMed ID: 16670180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-beta deposition in the cerebral cortex in Dementia with Lewy bodies is accompanied by a relative increase in AbetaPP mRNA isoforms containing the Kunitz protease inhibitor.
    Barrachina M; Dalfó E; Puig B; Vidal N; Freixes M; Castaño E; Ferrer I
    Neurochem Int; 2005 Feb; 46(3):253-60. PubMed ID: 15670642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease.
    Tsang SW; Lai MK; Kirvell S; Francis PT; Esiri MM; Hope T; Chen CP; Wong PT
    Neurobiol Aging; 2006 Sep; 27(9):1216-23. PubMed ID: 16129514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLC-beta1, activated via mGluRs, mediates activity-dependent differentiation in cerebral cortex.
    Hannan AJ; Blakemore C; Katsnelson A; Vitalis T; Huber KM; Bear M; Roder J; Kim D; Shin HS; Kind PC
    Nat Neurosci; 2001 Mar; 4(3):282-8. PubMed ID: 11224545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.
    Peng S; Wuu J; Mufson EJ; Fahnestock M
    J Neurochem; 2005 Jun; 93(6):1412-21. PubMed ID: 15935057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective changes of calcineurin (protein phosphatase 2B) activity in Alzheimer's disease cerebral cortex.
    Lian Q; Ladner CJ; Magnuson D; Lee JM
    Exp Neurol; 2001 Jan; 167(1):158-65. PubMed ID: 11161603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.